Inactief instrument

Andere talen Neurometrix Inc Nasdaq

Aandelen

US6412555004

slotkoers Nasdaq Andere beurzen
- ^USD	-

15/05	NeuroMetrix, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
19/04	Neurometrix, Inc. Benoemt Joshua S. Horowitz tot Klasse III Bestuurder in de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

NeuroMetrix Reports Q1 2024 Business Highlights	15/05
NeuroMetrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Sector Update: Health Care Stocks Advance Late Afternoon	19/04
Sector Update: Health Care Stocks Rise Friday Afternoon	19/04
NeuroMetrix Says Joshua Horowitz Joining Board, Terminates At-the-Market Equity Facility	19/04
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value	19/04
Neurometrix, Inc. Appoints Joshua S. Horowitz as a Class III director on the Board	19/04
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)	20/03
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	14/03
NeuroMetrix, Inc. Announces Publication of Study Demonstrating That DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	14/03
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia	13/03
Ephraim Fields Discloses his Views on NeuroMetrix	27/02
RS Fund Discloses its Views on NeuroMetrix	26/02
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights	22/02
NeuroMetrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
NeuroMetrix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call	15/02
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	13/02
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	13/02
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024	08/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Neurometrix Inc Nasdaq

Aandelen

US6412555004

Andere talen

Filters